Dr. Ashish Saxena, MD, PhD

Dr. Saxena practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Saxena's NPI, 1578882858, was assigned on May 25, 2010. Dr. Saxena graduated from Renaissance School of Medicine at Stony Brook University in 2006. Dr. Saxena's New York license number on file is 257512-1.

Dr. Saxena's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Saxena's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Saxena to 2 more clinical labs, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saxena practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Saxena's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Saxena has a license on file in New York.

Dmand AI lists lung cancer and lymphoma among the conditions Dr. Saxena treats.

CMS data shows 799 Medicare services from Dr. Saxena across 6 procedure codes in 2024, for 176 Medicare patients. Medicare paid $73,719 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 176 Medicare patients who saw Dr. Saxena in 2024. The largest group is 75 to 84, with 94 patients. 75% of them have cancer, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saxena's median patient age at 77, with 55% women.

In 2024, Dr. Saxena wrote 1,053 Medicare Part D claims for 148 patients. 59% of them were for generic drugs. CMS names the drug for 761 of them, across 21 drugs with 11 or more claims each, at $5,133,788 in total drug cost. In 2023, CMS named 446 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Saxena for performance year 2024, reported through an alternative payment model (APM). Dr. Saxena accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Saxena as offering telehealth.

Dmand AI links 41 papers to Dr. Saxena, published from 2012 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Carotid Stenosis. Dr. Saxena has published most often in Comput Biol Med. Dr. Saxena's most frequent co-authors are Nasser Altorki, MD, Mitchell S. Elkind, MD and Scott T. Tagawa, MD.

CMS Open Payments shows 156 general payments to Dr. Saxena from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Janssen Pharmaceuticals, Inc paid the most, $17,552.

Dmand AI lists 1 award for Dr. Saxena, most recently Outstanding House Officer in Ambulatory Care Medicine in 2010.

Dr. Saxena graduated from Renaissance School of Medicine at Stony Brook University in 2006.

Dr. Saxena is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.